Literature DB >> 17381536

A case report of therapeutic leukapheresis in an adult with chronic myelogenous leukemia presenting with hyperleukocytosis and leukostasis.

Shahzad Shafique1, Robert Bona, Andre A Kaplan.   

Abstract

Hyperleukocytosis (>100 x 10(9)/L) is an uncommon presentation of chronic leukemias. It can present with a variety of symptoms secondary to leukostasis, a syndrome caused by the sludging of circulating leukemic blasts in the microvasculature. The management includes hydration, cytoreduction, prevention of tumor lysis and, rarely, leukapheresis in cases complicated by leukostasis and hyperviscosity syndrome. We present a case of severe leukocytosis complicated by leukostasis in which leukapheresis was utilized to bring about a rapid reversal of microvascular sludging.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17381536     DOI: 10.1111/j.1744-9987.2007.00417.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  6 in total

1.  Leucapheresis for management of retinopathy in chronic myeloid leukaemia.

Authors:  Muhajir Mohamed; Carmen Oakley; Fiona McEwen; Georgina Connelley
Journal:  BMJ Case Rep       Date:  2015-12-01

2.  Therapeutic leukapheresis: 9-year experience in a University Hospital.

Authors:  Ingrid M Parra Salinas; Victoria P González Rodriguez; José A García-Erce
Journal:  Blood Transfus       Date:  2014-06-05       Impact factor: 3.443

3.  Is it always cancer? A curious case of benign intracranial hypertension in chronic myeloid leukemia.

Authors:  Purva V Sharma; Omar Ilyas; Yash Jobanputra; Teresita Casanova; Venkat Kalidindi; Napolean Santos
Journal:  Intractable Rare Dis Res       Date:  2018-08

4.  Effect of leukapheresis on pain reduction in leukemic priapism.

Authors:  Shahida Noushad; Dibyajyoti Sahoo; Abhishekh Basavarajegowda; Esha Toora; Purshotam Paudel
Journal:  Asian J Transfus Sci       Date:  2022-07-30

5.  Permanent sensorineural deafness in a patient with chronic myelogenous leukemia secondary to intracranial hemorrhage.

Authors:  Sakshi Kapur; Michael Wax; Levin Miles; Adnan Hussain
Journal:  Case Rep Hematol       Date:  2013-12-03

6.  Therapeutic leukocyte reduction for acute and chronic myeloid leukemias: A 4-year experience from an oncology center in India.

Authors:  Anita A Tendulkar; Puneet A Jain; Abhaykumar Gupta; Nidhi Sharma; Anisha Navkudkar; Vijaya Patle
Journal:  Asian J Transfus Sci       Date:  2017 Jul-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.